Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
1Division of Cardiology, University Hospital, Zurich, Switzerland. topole@ccf.org
European Heart Journal
|February 20, 2004
Summary
Diabetic patients with coronary artery disease benefit significantly from aggressive antithrombotic therapy and percutaneous coronary intervention. However, they still face a higher risk of repeat procedures, necessitating further research into advanced treatments.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Interventional Cardiology
Background:
- Diabetes mellitus is associated with inflammation and a prothrombotic state, increasing the risk of coronary artery disease.
- Diabetic patients experiencing non-ST-segment elevation acute coronary syndromes face a heightened risk of future cardiovascular events.
Purpose of the Study:
- To review the pathophysiologic mechanisms of diabetes-related coronary disease.
- To evaluate the benefits of aggressive antithrombotic therapy and percutaneous coronary intervention in diabetic patients.
- To identify areas for improvement in managing diabetic patients undergoing revascularization.
Main Methods:
- Review of current literature on diabetes, coronary artery disease, and interventional cardiology.
- Analysis of antithrombotic strategies and their efficacy in diabetic populations.
- Assessment of outcomes following percutaneous coronary intervention, including the role of drug-eluting stents.
Main Results:
- Diabetic patients experience greater benefits from aggressive antithrombotic therapy, early angiography, and stenting compared to non-diabetic individuals.
- Key antithrombotic agents include aspirin, clopidogrel, glycoprotein IIb/IIIa inhibitors, and heparin/low-molecular-weight heparin.
- Despite drug-eluting stents, diabetic patients remain at higher risk for restenosis and repeat revascularization due to excessive neointimal proliferation.
Conclusions:
- Aggressive antithrombotic therapy and percutaneous coronary intervention are crucial for managing diabetic patients with coronary artery disease.
- Further advancements in local drug elution and systemic therapies are required to mitigate neointimal hyperplasia and reduce repeat revascularization rates in this population.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...